• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

结直肠癌中的循环细胞角蛋白阳性细胞与肿瘤芽生

Circulating cytokeratin-positive cells and tumor budding in colorectal cancer.

作者信息

Märkl Bruno, Wilhelms Narjes, Anthuber Matthias, Schenkirsch Gerhard, Schlimok Günter, Oruzio Daniel

机构信息

Bruno Märkl, Narjes Wilhelms, Institute of Pathology, Klinikum Augsburg, 86156 Augsburg, Germany.

出版信息

World J Clin Oncol. 2016 Dec 10;7(6):433-440. doi: 10.5306/wjco.v7.i6.433.

DOI:10.5306/wjco.v7.i6.433
PMID:28008384
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5143437/
Abstract

AIM

To investigate whether circulating cytokeratin-positive (CK) cells in the mesenteric blood of resected colorectal specimens are prognostic and correlate with tumor budding.

METHODS

Fifty-six colorectal specimens were collected between 9/2007 and 7/2008. Blood from the mesenteric vein was drawn immediately after receiving the fresh and unfixed specimens in the pathology department. After separation of the mononuclear cells by Ficoll-Hypaque density-gradient centrifugation, cytological smears were immunocytochemically stained for CK18. Tumor budding was evaluated on slides stained for pan-cytokeratin. The identification of ≥ 30 buds/1.3 mm was defined as high grade budding.

RESULTS

CK cells and clusters were identified in 29 (48%) and 14 (25%) of the samples, respectively. Two cells were identified in one of three non-malignant cases. Clusters were found exclusively in malignant cases. The occurrence of CK cells or clusters was not associated with any of the evaluated clinicopathological factors, including surgical technique and tumor budding. Moreover, the occurrence of CK cells or clusters had no influence on the cancer-specific survival [75 mo (CI: 61; 88) 83 mo (CI: 72; 95) and 80 mo (CI: 63; 98) 79 mo (CI: 69; 89), respectively].

CONCLUSION

CK cells and showed neither prognostic significance nor an association with tumor budding. It is very likely that CK18-staining is not specific enough to identify the relevant cells.

摘要

目的

研究切除的结直肠标本肠系膜血中循环细胞角蛋白阳性(CK)细胞是否具有预后价值以及是否与肿瘤芽生相关。

方法

2007年9月至2008年7月收集了56份结直肠标本。在病理科接收新鲜未固定标本后,立即从肠系膜静脉采血。通过Ficoll-Hypaque密度梯度离心分离单核细胞后,对细胞涂片进行CK18免疫细胞化学染色。在全细胞角蛋白染色的玻片上评估肿瘤芽生情况。将≥30个芽/1.3 mm定义为高级别芽生。

结果

分别在29份(48%)和14份(25%)样本中鉴定出CK细胞和细胞簇。在3例非恶性病例中的1例中发现了2个细胞。细胞簇仅在恶性病例中发现。CK细胞或细胞簇的出现与任何评估的临床病理因素均无关,包括手术技术和肿瘤芽生。此外,CK细胞或细胞簇的出现对癌症特异性生存无影响[分别为75个月(CI:61;88)对83个月(CI:72;95)以及80个月(CI:63;98)对79个月(CI:69;89)]。

结论

CK细胞既无预后意义,也与肿瘤芽生无关。很可能CK18染色不足以特异性地识别相关细胞。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e92/5143437/c768790a41c3/WJCO-7-433-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e92/5143437/eb53f4aa4fad/WJCO-7-433-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e92/5143437/9a2068c206ce/WJCO-7-433-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e92/5143437/c768790a41c3/WJCO-7-433-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e92/5143437/eb53f4aa4fad/WJCO-7-433-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e92/5143437/9a2068c206ce/WJCO-7-433-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e92/5143437/c768790a41c3/WJCO-7-433-g003.jpg

相似文献

1
Circulating cytokeratin-positive cells and tumor budding in colorectal cancer.结直肠癌中的循环细胞角蛋白阳性细胞与肿瘤芽生
World J Clin Oncol. 2016 Dec 10;7(6):433-440. doi: 10.5306/wjco.v7.i6.433.
2
Digital image analysis of pan-cytokeratin stained tumor slides for evaluation of tumor budding in pT1/pT2 colorectal cancer: Results of a feasibility study.用于评估pT1/pT2期结直肠癌肿瘤芽生的全细胞角蛋白染色肿瘤切片的数字图像分析:一项可行性研究的结果
Pathol Res Pract. 2018 Sep;214(9):1273-1281. doi: 10.1016/j.prp.2018.07.002. Epub 2018 Jul 10.
3
Cytokeratin-based assessment of tumour budding in colorectal cancer: analysis in stage II patients and prospective diagnostic experience.基于细胞角蛋白的结直肠癌肿瘤芽评估:II期患者分析及前瞻性诊断经验
J Pathol Clin Res. 2017 Jul 26;3(3):171-178. doi: 10.1002/cjp2.73. eCollection 2017 Jul.
4
Tumor Budding Assessment with Cytokeratin and Its Significance in Laryngeal Squamous Cell Carcinomas.细胞角蛋白用于肿瘤芽生评估及其在喉鳞状细胞癌中的意义
Indian J Otolaryngol Head Neck Surg. 2022 Dec;74(4):494-500. doi: 10.1007/s12070-021-02981-3. Epub 2021 Nov 17.
5
Tumor budding in colorectal cancer revisited: results of a multicenter interobserver study.结直肠癌中的肿瘤芽生再探讨:一项多中心观察者间研究的结果
Virchows Arch. 2015 May;466(5):485-93. doi: 10.1007/s00428-015-1740-9. Epub 2015 Feb 21.
6
Co-expression of cytokeratin and vimentin in colorectal cancer highlights a subset of tumor buds and an atypical cancer-associated stroma.结直肠癌中细胞角蛋白和波形蛋白的共表达突出了肿瘤芽的一个子集和非典型的癌相关基质。
Hum Pathol. 2019 May;87:18-27. doi: 10.1016/j.humpath.2019.02.002. Epub 2019 Feb 20.
7
Automatic evaluation of tumor budding in immunohistochemically stained colorectal carcinomas and correlation to clinical outcome.免疫组化染色结直肠癌中肿瘤芽生的自动评估及其与临床结局的相关性
Diagn Pathol. 2018 Aug 28;13(1):64. doi: 10.1186/s13000-018-0739-3.
8
Evaluation of Tumor Budding in Primary Colorectal Cancer and Corresponding Liver Metastases Based on H&E and Pancytokeratin Staining.基于苏木精-伊红染色和全细胞角蛋白染色评估原发性结直肠癌及相应肝转移灶中的肿瘤芽生
Front Med (Lausanne). 2019 Oct 31;6:247. doi: 10.3389/fmed.2019.00247. eCollection 2019.
9
Paving the way to tumor budding assessment using digital pathology: a pilot study in Timişoara City (Romania).为使用数字病理学进行肿瘤芽评估铺平道路:在蒂米什瓦拉市(罗马尼亚)的一项试点研究。
Rom J Morphol Embryol. 2018;59(3):703-713.
10
Differential clinical impacts of tumour budding evaluated by the use of immunohistochemical and haematoxylin and eosin staining in stage II colorectal cancer.肿瘤微浸润评估对Ⅱ期结直肠癌临床影响的差异:免疫组化与苏木精-伊红染色法的对比研究。
Histopathology. 2019 Jun;74(7):1005-1013. doi: 10.1111/his.13830. Epub 2019 Apr 1.

引用本文的文献

1
Impact of uPA/PAI-1 and disseminated cytokeratin-positive cells in breast cancer.尿激酶型纤溶酶原激活物/纤溶酶原激活物抑制物-1 及其在乳腺癌中表达的意义
BMC Cancer. 2019 Jul 15;19(1):692. doi: 10.1186/s12885-019-5857-0.
2
Effect of microRNA-370 on coronary atherosclerosis and its underlying mechanism.微小RNA-370对冠状动脉粥样硬化的影响及其潜在机制。
Exp Ther Med. 2019 Jan;17(1):115-122. doi: 10.3892/etm.2018.6961. Epub 2018 Nov 13.
3
Circulating Tumor Cell-Derived Pre-Clinical Models for Personalized Medicine.用于个性化医疗的循环肿瘤细胞衍生的临床前模型

本文引用的文献

1
Microsatellite Instability as a Biomarker for PD-1 Blockade.微卫星不稳定性作为 PD-1 阻断的生物标志物。
Clin Cancer Res. 2016 Feb 15;22(4):813-20. doi: 10.1158/1078-0432.CCR-15-1678.
2
Detection and Clinical Significance of Circulating Tumor Cells in Colorectal Cancer--20 Years of Progress.结直肠癌中循环肿瘤细胞的检测及其临床意义——20年进展
Mol Med. 2015 Oct 27;21 Suppl 1(Suppl 1):S25-31. doi: 10.2119/molmed.2015.00149.
3
PD-1 Blockade in Tumors with Mismatch-Repair Deficiency.错配修复缺陷肿瘤中的程序性死亡受体-1阻断
Cancers (Basel). 2018 Dec 24;11(1):19. doi: 10.3390/cancers11010019.
N Engl J Med. 2015 Nov 12;373(20):1979. doi: 10.1056/NEJMc1510353.
4
The consensus molecular subtypes of colorectal cancer.结直肠癌的共识分子亚型
Nat Med. 2015 Nov;21(11):1350-6. doi: 10.1038/nm.3967. Epub 2015 Oct 12.
5
Circulating CD133(+)/ESA(+) cells in colorectal cancer patients.结直肠癌患者循环中的CD133(+)/ESA(+)细胞。
J Surg Res. 2015 Dec;199(2):362-70. doi: 10.1016/j.jss.2015.05.057. Epub 2015 Jun 4.
6
Epithelial-mesenchymal transition in colorectal cancer metastasis: A system review.结直肠癌转移中的上皮-间质转化:一项系统综述。
Pathol Res Pract. 2015 Aug;211(8):557-69. doi: 10.1016/j.prp.2015.05.010. Epub 2015 May 28.
7
Genomic classifier ColoPrint predicts recurrence in stage II colorectal cancer patients more accurately than clinical factors.基因组分类器ColoPrint在预测II期结直肠癌患者复发方面比临床因素更准确。
Oncologist. 2015 Feb;20(2):127-33. doi: 10.1634/theoncologist.2014-0325. Epub 2015 Jan 5.
8
Circulating tumour cells and the epithelial mesenchymal transition in colorectal cancer.循环肿瘤细胞与结直肠癌中的上皮-间质转化
J Clin Pathol. 2014 Oct;67(10):848-53. doi: 10.1136/jclinpath-2014-202499.
9
Circulating tumour cells: the evolving concept and the inadequacy of their enrichment by EpCAM-based methodology for basic and clinical cancer research.循环肿瘤细胞:不断发展的概念及其基于 EpCAM 的富集方法在基础和临床癌症研究中的不足。
Ann Oncol. 2014 Aug;25(8):1506-16. doi: 10.1093/annonc/mdu018. Epub 2014 Mar 20.
10
Towards the introduction of the 'Immunoscore' in the classification of malignant tumours.迈向“免疫评分”在肿瘤良恶性分类中的引入。
J Pathol. 2014 Jan;232(2):199-209. doi: 10.1002/path.4287.